Actively Recruiting
Near-Infrared Image-Guided Lung Lesion Removal and Targeted Lymph Node Mapping Using Indocyanine Green
Led by Massachusetts General Hospital · Updated on 2025-11-10
100
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of a near-infrared dye called indocyanine green ICG to help identify lung lesions and the sentinel lymph nodes, which are the first lymph nodes that drain from a tumor. This trial aims to see if injecting ICG near the tumor during surgery can improve the detection and removal of lymph nodes that may contain cancer cells, potentially improving lung cancer surgery outcomes. The study also assesses the safety and feasibility of this imaging method during surgery. Participants will receive an injection of ICG dye around the lung lesion or inside the nearby bronchus at the time of their surgery. The injection is done using navigational bronchoscopy, CT-guided, or transthoracic methods depending on the tumors location. Using a special near-infrared camera, surgeons will visualize fluorescent lymph nodes to guide their removal. After identifying sentinel lymph nodes with this imaging, the surgeon will proceed with tumor removal and standard lymph node dissection. During the study, patients will be monitored for safety and any side effects related to the ICG injection and imaging process for up to five years. Researchers will also analyze whether this imaging helps better detect metastatic disease in lymph nodes and whether the findings predict disease recurrence. Follow-up care includes standard monitoring for cancer recurrence as managed by the patients surgeon.
CONDITIONS
Brief Title
Bronchial NIR Image-guided Resection
Research Team
Y
Yolonda Colson, MD, PhD
I
Isha Mehta Warikoo, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here